Drug Approvals
IPO Gives Chinese Couple a 'Hansoh' Sum
The initial public offering of Hansoh Pharmaceutical Group made the Chinese couple Zhong Huijuan and Sun Piaoyang the richest in the nation.
Jim Cramer: A Tale of Two Stocks
I want you to remember Eli Lilly and Johnson & Johnson the next time you are about to dump a stock because of some bits of bad news.
2 Small Biotechs With Sagging Shares but Promising Prospects
The stocks of these two developmental concerns have slid recently, but there are reasons to believe they will improve.
Buy Stocks at a Big Discount With These 7 Closed-End Funds
Closed-end funds provide several benefits to investors over mutual funds.
Watch These 9 Companies in a Botox Export Boom Out of South Korea
South Korea is the plastic surgery capital of the world. These companies are manufacturing botox strains - but the big business is abroad, if they can crack the China and U.S. markets.
Hopeful Signs for These 2 Small Biotech Stocks
Few parts of this biotech space are more frustrating that what I have dubbed 'Tier 3' biotech concerns.
Teva Pharmaceuticals CEO: Stock on Track for 2020 Turnaround
But is a Teva turnaround still coming after the stock's 70% loss in the past five years?
Johnson & Johnson or Pfizer: Which Big Pharma Dividend Stock Is a Better Buy?
Healthcare giants Johnson & Johnson and Pfizer offer a tough choice for dividend investors seeking the best returns.
What's Next for Biogen After It Terminates Trials for Alzheimer's Drug?
Biogen has to now be considered a more likely buyout target given the breadth of its product portfolio.
Activists Aim to Eliminate Dual Role for Allergan CEO Saunders
David Tepper's Appaloosa LP renews calls for changes at the top.